Praziquantel And Pyrantel As The Embonate, Oxantel (Canine All Wormer)

Verify with FDA CVM →

10 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
2
Deaths Reported
2000.0%
Death Rate

Active Ingredients

Praziquantel And Pyrantel As The Embonate, Oxantel (Canine All Wormer)

Administration Routes

UnknownOral

Species Affected

Dog 9
Cat 1

Most Affected Breeds

Spitz - German Pomeranian 1
Retriever - Golden 1
Shepherd Dog - Australian 1
Mixed (Dog) 1
Bulldog - French 1
Boxer (German Boxer) 1
Shepherd Dog - German 1
Domestic Shorthair 1
Pointer (unspecified) 1
Terrier (unspecified) 1

Most Reported Reactions

Death by euthanasia 2
Vomiting 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Diarrhoea 2
Expired drug administered 1
Lack of efficacy (endoparasite) - tapeworm 1
Neutropenia 1
Leucopenia NOS 1
Lack of efficacy (protozoa) - Coccidia 1
Lack of efficacy - NOS 1
Seizure NOS 1
Lymphopenia 1

Outcome Breakdown

Ongoing
7 (70.0%)
Euthanized
2 (20.0%)
Recovered/Normal
1 (10.0%)

Data Summary

Metric Value
Total adverse event reports 10
Reports involving death 2
Case-fatality rate (reported events) 2000.0%
Distinct species in reports 2
Distinct breeds in reports 10
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Praziquantel And Pyrantel As The Embonate, Oxantel (Canine All Wormer) Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 10 adverse event reports referencing Praziquantel And Pyrantel As The Embonate, Oxantel (Canine All Wormer), including 2 reports in which the animal died — a 2000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Praziquantel And Pyrantel As The Embonate, Oxantel (Canine All Wormer). Reported administration routes include Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Praziquantel And Pyrantel As The Embonate, Oxantel (Canine All Wormer) reports are Dog (9 reports), Cat (1 reports), with Dog accounting for the largest share. Within those species, Spitz - German Pomeranian (1), Retriever - Golden (1), Shepherd Dog - Australian (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Praziquantel And Pyrantel As The Embonate, Oxantel (Canine All Wormer) are Death by euthanasia (2), Vomiting (2), Lethargy (see also Central nervous system depression in 'Neurological') (2), Diarrhoea (2). Of the 10 reports with a coded outcome, Ongoing is the leading category at 70.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Praziquantel And Pyrantel As The Embonate, Oxantel (Canine All Wormer).

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial